Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2.
Journal:
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
PMID:
26775128
Abstract
BACKGROUNDS: The effect of metformin on survival in patients with pancreatic cancer is controversial.
Authors
Keywords
Adult
Aged
Aged, 80 and over
CA-19-9 Antigen
Diabetes Mellitus, Type 2
Female
Humans
Hypoglycemic Agents
Kaplan-Meier Estimate
Male
Metformin
Middle Aged
Multivariate Analysis
Neoplasm Staging
Pancreatic Neoplasms
Prognosis
Proportional Hazards Models
Republic of Korea
Retrospective Studies
Survival Rate